Valine

Category
amino acid
Routes
Oral (PO)
Half-Life (t½)
PO: 1h
Formula
C5H11NO2
Molecular Weight
117.15 g/mol
PubChem CID
6287
Aliases
Val, V, L-Valine, BCAA

Pharmacological Mechanism

One of three BCAAs. Glucogenic (catabolised to succinyl-CoA). Catabolised extrahepatically by BCKDH — same enzyme complex as Leu/Ile. Deficiency in MSUD (maple syrup urine disease).

Half-Life & Elimination Curve (PO: 1h)

100%50%25%12.5%0%0h0×t½1h1×t½2h2×t½3h3×t½4h4×t½5h5×t½0×t½ (0h): 100% remaining (~82.6 mg/L)1×t½ (1h): 50% remaining (~41.3 mg/L)2×t½ (2h): 25% remaining (~20.7 mg/L)3×t½ (3h): 12.5% remaining (~10.3 mg/L)4×t½ (4h): 6.3% remaining (~5.16 mg/L)5×t½ (5h): 3.1% remaining (~2.58 mg/L)
Plasma (PO)t½ Decay (1h)
  • 0×t½0h100% (82.6 mg/L)
  • 1×t½1h50% (41.3 mg/L)
  • 2×t½2h25% (20.7 mg/L)
  • 3×t½3h12.5% (10.3 mg/L)
  • 4×t½4h6.3% (5.16 mg/L)
  • 5×t½5h3.1% (2.58 mg/L)
Elimination t½1h (PO)
Rate Constant (ke)0.693 h⁻¹
Time to Peak (Tmax)49m
Est. Peak (Cmax)82.6 mg/L
Clearance (CL)12.1 L/h
97% Washout (5×t½)5h

Dosing Guidelines

Pharmacokinetic Parameters

Pathways It Modulates

Target Organ Systems

Interactions

Top Dietary Sources

Chemical Structure & Identifiers

References